Pfizer's (PFE) Lipitor cholesterol pill lost about 15% of its market share in the first few days...


Pfizer's (PFE) Lipitor cholesterol pill lost about 15% of its market share in the first few days after its patent protection ended on November 30. Meanwhile, the pharmaceutical manufacturer yesterday named CEO Ian Read as Chairman to replace George Lorch, who becomes Lead Independent Director.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs